Cited by 2,049MicroRNA in disease regulationCancer-related molecular mechanisms researchCancer-related Molecular Pathways

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

MicroRNAs in cancer: biomarkers, functions and therapy

Open access

Hayes, Josie, Peruzzi, Pier Paolo, Lawler, Sean·2014·Trends in Molecular Medicine

DOI 10.1016/j.molmed.2014.06.005

Open this paper in CoChat — free account Open PDF

Abstract

The emergence of microRNAs has been one of the defining developments in cancer biology over the past decade, and the explosion of knowledge in this area has brought forward new diagnostic and therapeutic opportunities. The importance of microRNAs in cancer has been underlined by the identification of alterations in microRNA target binding sites and the microRNA processing machinery in tumor cells. Clinical trials utilizing microRNA profiling for patient prognosis and clinical response are now underway, and the first microRNA mimic entered the clinic for cancer therapy in 2013. In this article we review the potential applications of microRNAs for the clinical assessment of patient outcome in cancer, as well as in cancer monitoring and therapy.

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2014.06.005

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

1 retracted

HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2013) · Nature · doi:10.1038/nature12785 · Cited by 255
Retracted
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
miRBase: tools for microRNA genomics
Griffiths‐Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,432
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262

Flagged first, then by citations

Show all 79 references

Research works printed but not linked: 1

Choudhury, 2012, Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells, J. Clin. Invest., 122, 4059, 10.1172/JCI62925 · DOI

Sorted by citations

Items 201–300 of 1,000

MiR‐214 is an important regulator of the musculoskeletal metabolism and disease
Sun, Y., Kuek, V., Liu, Y., Tickner, J. C., Yuan, Y. J., Chen, L., Zeng, Z., Shao, M., He, W., & Xu, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26856 · Cited by 83
The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis
Zhao, F., Xie, X., Tan, X., Yu, H., Tian, M., Lv, H., Qin, C., Qi, J., & Zhu, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691766 · Cited by 86
Genome-wide analysis of microRNA and mRNA expression signatures in cancer
Li, M., Fu, S., & Xiao, H. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.67 · Cited by 80
Biomarkers: background, classification and guidelines for applications in nutritional epidemiology.
Corella, D., & Ordovás, J. M. (2015) · PubMed · doi:10.3305/nh.2015.31.sup3.8765 · Cited by 85
MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1
Zhang, Z., Chen, W., Wu, Y., Liang, H., & Zhang, B. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.049 · Cited by 79
Targeting MicroRNA Function in Respiratory Diseases: Mini-Review
Maltby, S., Plank, M. W., Tay, H. L., Collison, A., & Foster, P. S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00021 · Cited by 78
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
Vescarelli, E., Gerini, G., Megiorni, F., Anastasiadou, E., Pontecorvi, P., Solito, L., Vitis, C. D., Camero, S., Marchetti, C., Mancini, R., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1490-7 · Cited by 81
Attomolar analyte sensing techniques (AttoSens): a review on a decade of progress on chemical and biosensing nanoplatforms
Usha, S. P., Manoharan, H., Deshmukh, R. A., Álvarez-Diduk, R., Calucho, E., Sai, V. V. R., & Merkoçi, A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00137j · Cited by 79
MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A
Liu, M., Zhang, Y., Zhang, J., Cai, H., Zhang, C., Yang, Z., Niu, Y., Wang, H., Wei, X., Wang, W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0218-x · Cited by 77
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer
Papadaki, C., Stratigos, M., Markakis, G., Spiliotaki, M., Mastrostamatis, G., Nikolaou, C., Mavroudis, D., & Agelaki, S. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1001-3 · Cited by 77
Circulating Biomarkers for Glioma: A Review
Jones, J., Nguyen, H. P. T., Drummond, K. J., & Morokoff, A. P. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa540 · Cited by 82
Current paradigms in epigenetic anticancer therapeutics and future challenges
Singh, M. P., Kumar, V., Sehrawat, N., Yadav, M. K., Chaudhary, M., Upadhyay, S. K., Kumar, S., Sharma, V., Kumar, S., Dilbaghi, N., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.013 · Cited by 78
Enhancing the Sensitivity of Photoelectrochemical DNA Biosensing Using Plasmonic DNA Barcodes and Differential Signal Readout
Victorious, A. P., Saha, S., Pandey, R., & Soleymani, L. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202014329 · Cited by 76
RBP-J–Regulated miR-182 Promotes TNF-α–Induced Osteoclastogenesis
Miller, C. H., Smith, S. M., Elguindy, M. M., Zhang, T., Xiang, J., Hu, X., Ivashkiv, L. B., & Zhao, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502044 · Cited by 77
Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin
Chen, W., Zhou, Y., Zhi, X., Ma, T., Liu, H., Chen, B. W., Zheng, X., Xie, S., Zhao, B., Feng, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.035 · Cited by 76
Exosomal miRNAs: Novel Players in Viral Infection
Nahand, J. S., Mahjoubin‐Tehran, M., Moghoofei, M., Pourhanifeh, M. H., Mirzaei, H. R., Asemi, Z., Khatami, A., Bokharaei‐Salim, F., Mirzaei, H., & Hamblin, M. R. (2020) · Epigenomics · doi:10.2217/epi-2019-0192 · Cited by 75
Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis
Peng, N., He, J., Li, J., Huang, H., Huang, W., Liao, Y., & Zhu, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01231-w · Cited by 77
Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers
Pourhanifeh, M. H., Vosough, M., Mahjoubin‐Tehran, M., Hashemipour, M., Nejati, M., Abbasi‐Kolli, M., Sahebkar, A., & Mirzaei, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105133 · Cited by 76
MicroRNA‐206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto‐oncogene and cyclin‐dependent kinase 6 in mice
Wu, H., Tao, J., Li, X., Zhang, T., Zhao, L., Wang, Y., Zhang, L., Xiong, J., Zeng, Z. R., Zhan, N., et al. (2017) · Hepatology · doi:10.1002/hep.29374 · Cited by 74
QKI, a miR‐200 target gene, suppresses epithelial‐to‐mesenchymal transition and tumor growth
Kim, E. J., Kim, J. S., Lee, S., Lee, H., Yoon, J., Hong, J. H., Chun, S. H., Sun, D. S., Won, H. S., Hong, S. A., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32372 · Cited by 74
The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer
Muralidhar, G. G., & Barbolina, M. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816833 · Cited by 74
Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer
Costea, T., Nagy, P., Ganea, C., Szöllõsi, J., & Mocanu, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051062 · Cited by 77
Comparison of MicroRNA Expression in Tears of Normal Subjects and Sjögren Syndrome Patients
Kim, K. G., Yeon, Y., Lee, W. J., Shin, Y. U., Cho, H., Sung, Y., Kim, D. R., Lim, H. W., & Kang, M. H. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27062 · Cited by 74
XIST promotes gastric cancer (GC) progression through TGF‐β1 via targeting miR‐185
Zhang, Q., Chen, B., Liu, P., & Yang, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26447 · Cited by 73
miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma
Xiao, H., Xiao, W., Cao, J., Li, H., Guan, W., Guo, X., Chen, K., Zheng, T., Ye, Z., Wang, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.032 · Cited by 72
The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells
Colangelo, T., Polcaro, G., Ziccardi, P., Muccillo, L., Galgani, M., Pucci, B., Milone, M. R., Budillon, A., Santopaolo, M., Mazzoccoli, G., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.29 · Cited by 73
A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy
Farr, R. J., Januszewski, A. S., Joglekar, M. V., Liang, H. H., McAuley, A. K., Hewitt, A. W., Thomas, H. E., Loudovaris, T., Kay, T. W. H., Jenkins, A. J., et al. (2015) · Scientific Reports · doi:10.1038/srep10375 · Cited by 73
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells
Vitiello, M., Tuccoli, A., D’Aurizio, R., Sarti, S., Giannecchini, L., Lubrano, S., Marranci, A., Evangelista, M., Peppicelli, S., Ippolito, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15915 · Cited by 73
TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4
Wei, C., Wang, L., Zhu, M.-X., Deng, X., Wang, D., Zhang, S., Ying, J., Yuan, X., Wang, Q., Xuan, T., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1138-7 · Cited by 71
Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells
Bie, B., Sun, J., Li, J., Guo, Y., Jiang, W., Huang, C. Y., Yang, J. J., & Li, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000470815 · Cited by 71
Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression
Carden, T., Singh, B. P., Mooga, V. P., Bajpai, P., & Singh, K. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797001 · Cited by 71
G-Quadruplexes influence pri-microRNA processing
Rouleau, S. G., Garant, J., Bolduc, F., Bisaillon, M., & Perreault, J. (2017) · RNA Biology · doi:10.1080/15476286.2017.1405211 · Cited by 72
What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
Palmini, G., Marini, F., & Brandi, M. L. (2017) · Molecules · doi:10.3390/molecules22030417 · Cited by 70
Non-covalent Methods of Engineering Optical Sensors Based on Single-Walled Carbon Nanotubes
Gillen, A. J., & Boghossian, A. A. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00612 · Cited by 70
miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Du, F., Yu, L., Wu, Y., Wang, S., Yao, J., Zheng, X., Xie, S., Zhang, S., Lu, X., Liu, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2164-2 · Cited by 70
MicroRNA based Pan-Cancer Diagnosis and Treatment Recommendation
Cheerla, N., & Gevaert, O. (2017) · BMC Bioinformatics · doi:10.1186/s12859-016-1421-y · Cited by 70
MicroRNA‐induced silencing in epilepsy: Opportunities and challenges for clinical application
Tiwari, D., Peariso, K., & Groß, C. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24582 · Cited by 70
Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives
Ausoni, S., Boscolo‐Rizzo, P., Singh, B., Mosto, M. C. D., Spinato, G., Tirelli, G., Spinato, R., & Azzarello, G. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9625-1 · Cited by 71
“Dual-Signal-On” Integrated-Type Biosensor for Portable Detection of miRNA: Cas12a-Induced Photoelectrochemistry and Fluorescence Strategy
Shen, H., Qileng, A., Yang, H. Y., Liang, H., Zhu, H., Liu, Y., Lei, H., & Liu, W. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02395 · Cited by 69
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
Koschmieder, S., & Vetrie, D. L. P. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.006 · Cited by 70
MicroRNA-92 Expression in CD133+ Melanoma Stem Cells Regulates Immunosuppression in the Tumor Microenvironment via Integrin-Dependent Activation of TGFβ
Shidal, C., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2659 · Cited by 71
Efficient and Exponential Rolling Circle Amplification Molecular Network Leads to Ultrasensitive and Label-Free Detection of MicroRNA
Li, D., Zhang, T., Yang, F., Yuan, R., & Xiang, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04585 · Cited by 69
Cofilin: A Promising Protein Implicated in Cancer Metastasis and Apoptosis
Xu, J., Huang, Y., Zhao, J., Wu, L., Qi, Q., Liu, Y., Li, G., Li, J., Liu, H., & Wu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.599065 · Cited by 73
Crosstalk between miRNAs and DNA Methylation in Cancer
Saviana, M., Le, P., Micalo, L., Morales, D. D. V., Romano, G., Acunzo, M., Li, H. Y., & Nana-Sinkam, P. S. (2023) · Genes · doi:10.3390/genes14051075 · Cited by 72
MicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2
Sun, X., & Zhang, L. (2017) · Bioscience Reports · doi:10.1042/bsr20160404 · Cited by 68
MicroRNA‐124: An emerging therapeutic target in cancer
Jia, X., Wang, X., Guo, X., Ji, J., Lou, G., Zhao, J., Zhou, W., Guo, M., Zhang, M., Li, C., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2489 · Cited by 68
Long Noncoding RNA XIST Promotes Osteosarcoma Progression by Targeting Ras-Related Protein RAP2B via miR-320b
Gongyi, L., Miao, J., & Zhang, X. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14920318811721 · Cited by 67
Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters
LaRocca, D., Barns, S., Hicks, S. D., Brindle, A., Williams, J. R., Uhlig, R., Johnson, P. R., Neville, C., & Middleton, F. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0207785 · Cited by 68
IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
Zhu, X., Shen, H., Yin, X., Long, L., Chen, X., Feng, F., Liu, Y., Zhao, P., Xu, Y., Li, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16610 · Cited by 67
Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals
Baskaran, R., & Velmurugan, B. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.077 · Cited by 67
Circular RNA circ‐EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR‐1299‐mediated IRF7 activation
Lin, L., & Cai, J. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29620 · Cited by 66
circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling
Zheng, X., Shu, R., Wang, X., Zou, X., Gong, Y., & Li, Z. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01964-0 · Cited by 66
Development and validation of a circulating microRNA panel for the early detection of breast cancer
Zou, R., Loke, S. Y., Tang, Y. C., Too, H., Zhou, L., Lee, A. S. G., & Hartman, M. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01593-6 · Cited by 66
Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model
Chi, H., Chen, H., Wang, R., Zhang, J., Jiang, L., Zhang, S., Jiang, C., Huang, J., Quan, X., Liu, Y., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1244578 · Cited by 66
The Role of Wnt Signaling in Squamous Cell Carcinoma
Shiah, S., Shieh, Y., & Chang, J. (2015) · Journal of Dental Research · doi:10.1177/0022034515613507 · Cited by 66
Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis
Li, B., Jin, X., Hui-lin, M. E. N. G., Hu, B., Zhang, T., Jiang, Y. L., Chen, S., Guo, X., Wang, W., Jiang, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18133 · Cited by 66
Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN–AKT axis
Coronel-Hernández, J., López–Urrutia, E., Contreras-Romero, C., Delgado-Waldo, I., Figueroa‐González, G., Campos-Parra, A. D., Salgado-García, R., Martínez-Gutiérrez, A. D., Rodríguez-Morales, M., Jacobo-Herrera, N. J., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0802-5 · Cited by 65
Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis
Deng, T., Yuan, Y., Zhang, C., Zhang, C., Yao, W., Wang, C., Liu, R., & Ba, Y. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447872 · Cited by 65
Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer
Zhang, J., Raju, G. S., Chang, D. W., Lin, S., Chen, Z., & Wu, X. (2017) · Cancer · doi:10.1002/cncr.31062 · Cited by 65
microRNAs: Key players in virus‐associated hepatocellular carcinoma
Nahand, J. S., Bokharaei‐Salim, F., Salmaninejad, A., Nesaei, A., Mohajeri, F., Moshtzan, A., Tabibzadeh, A., Karimzadeh, M. R., Moghoofei, M., Marjani, A., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27956 · Cited by 65
A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients
Dobrowolny, G., Martone, J., Lepore, E., Casola, I., Petrucci, A., Inghilleri, M., Morlando, M., Colantoni, A., Scicchitano, B. M., Calvo, A., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-020-00397-6 · Cited by 67
NEAT1 upregulates TGF‐β1 to induce hepatocellular carcinoma progression by sponging hsa‐mir‐139‐5p
Tu, J., Zhao, Z., Xu, M., Lu, X., Liu, C., & Ji, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26524 · Cited by 64
Regulation of cytochrome P450 expression by microRNAs and long noncoding RNAs: Epigenetic mechanisms in environmental toxicology and carcinogenesis
Li, D., Tolleson, W. H., Yu, D., Chen, S., Guo, L., Xiao, W., Tong, W., & Ning, B. (2019) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2019.1639481 · Cited by 64
circRNA_0084043 contributes to the progression of diabetic retinopathy via sponging miR-140-3p and inducing TGFA gene expression in retinal pigment epithelial cells
Li, Y., Cheng, T., Wan, C., & Cang, Y. (2020) · Gene · doi:10.1016/j.gene.2020.144653 · Cited by 64
Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells
Xu, Y., Liu, N., Wei, Y.-H., Zhou, D., Lin, R., Wang, X., & Shi, B. (2020) · Aging · doi:10.18632/aging.103997 · Cited by 66
Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer
Li, Z., Li, L.-X., Diao, Y., Wang, J., Ye, Y., & Hao, X. (2021) · Cancer Management and Research · doi:10.2147/cmar.s272140 · Cited by 64
Involvement and Clinical Aspects of MicroRNA in Osteosarcoma
Kumar, R., Boro, A., & Fuchs, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060877 · Cited by 64
Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients
Yan, Y., Wang, X., Venø, M. T., Bakholdt, V. T., Sørensen, J. A., Krogdahl, A., Sun, Z., Gao, S., & Kjems, J. (2016) · Oncotarget · doi:10.18632/oncotarget.14143 · Cited by 64
miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma
Xie, F., Yuan, Y., Xie, L., Ran, P., Xiang, X., Huang, Q., Qi, G., Guo, X., Xiao, C., & Zheng, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s122992 · Cited by 64
Paclitaxel Response Can Be Predicted With Interpretable Multi-Variate Classifiers Exploiting DNA-Methylation and miRNA Data
Bomane, A., Gonçalvès, A., & Ballester, P. J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01041 · Cited by 65
Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
Rezaei, S., Mahjoubin‐Tehran, M., Aghaee‐Bakhtiari, S. H., Jalili, A., Movahedpour, A., Khan, H. Z., Moghoofei, M., Shojaei, Z., Hamblin, M. R., & Mirzaei, H. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103063 · Cited by 63
Regulation of Endoplasmic Reticulum–Mitochondria Ca2+ Transfer and Its Importance for Anti-Cancer Therapies
Pedriali, G., Rimessi, A., Sbano, L., Giorgi, C., Wieckowski, M. R., Previati, M., & Pinton, P. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00180 · Cited by 63
Study Design and qPCR Data Analysis Guidelines for Reliable Circulating miRNA Biomarker Experiments: A Review
de Ronde, M. W. J., Ruijter, J. M., Moerland, P. D., Creemers, E. E., & Pinto‐Sietsma, S. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.285288 · Cited by 63
miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer
Yu, Y., Yin, W., Yu, Z.-H., Zhou, Y., Chi, J.-R., Ge, J., & Cao, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1039-9 · Cited by 63
MicroRNA expression patterns in oral squamous cell carcinoma: hsa‐mir‐99b‐3p and hsa‐mir‐100‐5p as novel prognostic markers for oral cancer
Jakob, M., Mattes, L., Küffer, S., Unger, K., Heß, J., Bertlich, M., Haubner, F., Ihler, F., Canis, M., Weiss, B. G., et al. (2019) · Head & Neck · doi:10.1002/hed.25866 · Cited by 63
MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma
Zhang, W., Liu, K., Liu, S., Ji, B., Wang, Y., & Liu, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3749-8 · Cited by 62
Retracted
Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease?
Naqvi, A. R., Shango, J., Seal, A., Shukla, D., & Nares, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02099 · Cited by 63
miR-21-5p Regulates the Proliferation and Differentiation of Skeletal Muscle Satellite Cells by Targeting KLF3 in Chicken
Zhang, D., Ran, J., Li, J., Yu, C., Cui, Z., Amevor, F. K., Wang, Y., Jiang, X., Qiu, M., Du, H., et al. (2021) · Genes · doi:10.3390/genes12060814 · Cited by 62
MicroRNA-206 promotes the recruitment of CD8 + T cells by driving M1 polarisation of Kupffer cells
Liu, N., Wang, X., Steer, C. J., & Song, G. (2021) · Gut · doi:10.1136/gutjnl-2021-324170 · Cited by 63
RETRACTED ARTICLE: MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2
Fan, H., Ai, R., Mu, S., Niu, X., Guo, Z., & Liu, L. (2022) · Bioengineered · doi:10.1080/21655979.2022.2054194 · Cited by 62
Retracted
miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1
Akdemir, B., Nakajima, Y., Inazawa, J., & Inoue, J. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0232 · Cited by 62
MicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway
Zhang, Q., Zhang, B., Sun, L., Yan, Q., Zhang, Y., Zhang, Z., Su, Y., & Wang, C. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3331 · Cited by 62
Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition
Li, L., Pan, D., Chen, Q., Zhang, S.-W., Xie, D., Zheng, X., & Chen, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490871 · Cited by 62
miR‐497‐5p inhibits tumor cell growth and invasion by targeting SOX5 in non–small‐cell lung cancer
Li, G., Wang, K., Wang, J., Qin, S., Sun, X., & Ren, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28345 · Cited by 62
Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis
Ravegnini, G., Cargnin, S., Sammarini, G., Zanotti, F., Bermejo, J. L., Hrelia, P., Terrazzino, S., & Angelini, S. (2019) · Cancers · doi:10.3390/cancers11070970 · Cited by 62
The Function and Therapeutic Potential of Epstein-Barr Virus-Encoded MicroRNAs in Cancer
Wang, M., Gu, B., Chen, X., Wang, Y., Li, P., & Wang, K. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.07.002 · Cited by 62
MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R
Chen, G., Fang, T., Huang, Z., Qi, Y., Du, S., Di, T., Lei, Z., Zhang, X., & Yan, W. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438653 · Cited by 61
miR-1307 promotes the proliferation of prostate cancer by targeting FOXO3A
Qiu, X., & Dou, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.120 · Cited by 63
Prediction of clinical outcome in glioblastoma using a biologically relevant nine‐microRNA signature
Hayes, J. L., Thygesen, H. H., Tumilson, C. A., Droop, A., Boissinot, M., Hughes, T. A., Westhead, D. R., Alder, J. E., Shaw, L., Short, S. C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.004 · Cited by 61
Self-citation
Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis
Li, P., Guo, Y., Bledsoe, G., Yang, Z., Chao, L., & Chao, J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.004 · Cited by 62
Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer
Leao, R. R. N., Ahmad, A. E., & Hamilton, R. J. (2018) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2018.10.007 · Cited by 61
MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8
Mou, T., Xie, F., Zhong, P., Hua, H., Lai, L., Yang, Q., & Wang, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.121 · Cited by 61
miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7
Liu, X., Gan, L., & Zhang, J. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.036 · Cited by 61
Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer
Wang, J., Wu, A., Yang, B., Zhu, X., Teng, Y., & Ai, Z. (2019) · Gene · doi:10.1016/j.gene.2019.144150 · Cited by 60
Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer—Advances and Challenges
Seyhan, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713340 · Cited by 66
Meta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms
Lubov, J., Maschietto, M. C., Ibrahim, I., Mlynarek, A., Hier, M., Kowalski, L. P., Alaoui‐Jamali, M. A., & da Silva, S. D. (2017) · Oncotarget · doi:10.18632/oncotarget.19224 · Cited by 60
Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma
Rotondo, J. C., Mazziotta, C., Lanzillotti, C., Tognon, M. G., & Martini, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111464 · Cited by 59
Surface plasmon resonance: A promising approach for label-free early cancer diagnosis
Gade, A., Sharma, A., Srivastava, N., & Flora, S. J. S. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.01.023 · Cited by 59
Genetic alterations and epigenetic alterations of cancer-associated fibroblasts
Du, H., & Che, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.5451 · Cited by 63
miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
Hiramoto, H., Muramatsu, T., Ichikawa, D., Tanimoto, K., Yasukawa, S., Otsuji, E., & Inazawa, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04191-w · Cited by 59

Authors: Hayes, J., Peruzzi, P. P., & Lawler, S.
Affiliations: St James's University Hospital (GB)
The Ohio State University Wexner Medical Center (US)
Brigham and Women's Hospital (US)
Corresponding author: Lawler, Sean
ORCID: Hayes, Josie
Peruzzi, Pier Paolo
Lawler, Sean
Venue: Trends in Molecular Medicine
Publisher: Elsevier BV
Published: 2014-08
Volume: 20
Issue: 8
Pages: 460-469
ISSN: 1471-4914 (ISSN-L)
DOI: 10.1016/j.molmed.2014.06.005
OpenAlex: W1974254202
Cited by: 2,049
References: 79
Citations by year: 2026: 61 · 2025: 78 · 2024: 103 · 2023: 130 · 2022: 186 · 2021: 244 · 2020: 290 · 2019: 273 · 2018: 235 · 2017: 203 · 2016: 140 · 2015: 91 · 2014: 12
FWCI: 14.44
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Molecular Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: microRNA, cancer, biomarkers, microRNA processing, miRNA expression profiling, prognosis, cancer therapy, miRNA mimics, cancer monitoring
MeSH terms: Animals, Humans, Neoplasms, Prognosis, Biomarkers, Tumor, Genetic Therapy, Gene Expression Regulation, Neoplastic, MicroRNAs, Gene Regulatory Networks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNAs in cancer: biomarkers, functions and therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks